e-learning
resources
Munich 2014
Monday, 08.09.2014
Cells, biofilms and biomarkers in respiratory infections
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Intranasal administration of lipopolysaccharide (LPS) during a chronic pulmonary infection with
streptococcus pneumoniae
resulted in a synergistic effect on neutrophil influx in mice
L. Haste, K. Hulland, S. Bolton, P. Andrew (Leicester, United Kingdom)
Source:
International Congress 2014 – Cells, biofilms and biomarkers in respiratory infections
Session:
Cells, biofilms and biomarkers in respiratory infections
Session type:
Thematic Poster Session
Number:
2500
Disease area:
Airway diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Haste, K. Hulland, S. Bolton, P. Andrew (Leicester, United Kingdom). Intranasal administration of lipopolysaccharide (LPS) during a chronic pulmonary infection with
streptococcus pneumoniae
resulted in a synergistic effect on neutrophil influx in mice. Eur Respir J 2014; 44: Suppl. 58, 2500
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Chronic pulmonary infection with streptococcus pneumoniae during ovalbumin allergic inflammation
Source: Annual Congress 2013 –Pneumonia and sepsis
Year: 2013
A staphylococcus aureus pore-forming toxin subverts the activity of ADAM10 to cause lethal infection in mice
Source: International Congress 2014 – Resistance, bacteriological profile and comorbidities in respiratory infections
Year: 2014
Cellular and physiological characterisation of a murine model of long-term pulmonary infection with streptococcus pneumoniae
Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections
Year: 2013
The role of the type 3 secretion system effector protein ExoY during pathogenesis of
pseudomonas aeruginosa
lung infections
Source: International Congress 2014 – Pathogenesis and mechanisms of respiratory infections
Year: 2014
Broad spectrum of virulence of
pseudomonas aeruginosa
clones characterized in a murine airway infection model
Source: Annual Congress 2013 –Bacterial, fungal and mycobacterial infections
Year: 2013
Alteration of the immune response to streptococcus pneumoniae during COPD exacerbation in mice
Source: Annual Congress 2013 –COPD and infections
Year: 2013
Chronic pseudomonas aeruginosa airway infection induces peribronchial lymphoid neogenesis in mice
Source: Annual Congress 2013 –Stress responses and T-cell behaviour in the lung
Year: 2013
Impact of nasopharyngeal pneumococcal colonization on protective immunity against S. pneumoniae in mice
Source: International Congress 2015 – Advances from translational research in respiratory infections
Year: 2015
Pulmonary immunostimulation with macrophage-activating lipopeptide-2 in influenza-A-virus infected mice increased survival of subsequent pneumococcal pneumonia
Source: Annual Congress 2012 - Hot topics in respiratory infections
Year: 2012
The impact of time on the systemic inflammatory response in pneumococcal pneumonia
Source: Eur Respir J 2010; 35: 614-618
Year: 2010
Experimental Pseudomonas aeruginosa pneumonia: evaluation of the associated inflammatory response
Source: Eur Respir J 2007; 30: 1167-1172
Year: 2007
Mesenchymal stem cells enhance bacterial clearance of streptococcal pneumoniae and pseudomonas aeruginosa in the lung
Source: International Congress 2016 – Microbiological issues and translational research in respiratory infections
Year: 2016
Respiratory commensal streptococcus spp do not modulate the outcome of pseudomonas aeruginosa infection in vivo
Source: International Congress 2016 – Cystic fibrosis: various aspects
Year: 2016
Viral infection of macrophages reduces CD36 expression: Implications for phagocytosis of non-typeable haemophilus influenzae
Source: International Congress 2015 – Viral infections: basic research and clinical perspective
Year: 2015
Repeated lipopolysaccharide stimulation causes corticosteroid insensitive inflammation in lung via phosphoinositide-3-kinase δ signaling
Source: International Congress 2014 – New treatments for cough, asthma, COPD and ILDs
Year: 2014
Induction of the TGF-beta pseudoreceptor BAMBI by nontypeable haemophilus influenzae (NTHi) and its impact on TGF-beta induced effects
Source: International Congress 2014 – Cells, biofilms and biomarkers in respiratory infections
Year: 2014
Chlamydia pneumoniae enhances infection with Haemophilus influenzae, up-regulates TLR2-expression in human lung tissue and leads to enhanced chemokine production after coinfection – a possible mechanism for COPD exacerbations
Source: Annual Congress 2008 - New diagnostic methods in viral and atypical infections
Year: 2008
Relationship between the inoculum dose of Streptococcus pneumoniae and pneumonia onset in a rabbit model
Source: Eur Respir J 2005; 25: 693-700
Year: 2005
Parachlamydia acanthamoebae
as a respiratory pathogen: Challenge dose titration in a bovine model
Source: International Congress 2014 – Resistance, bacteriological profile and comorbidities in respiratory infections
Year: 2014
A molecule derived from mycobacterium tuberculosis
Cpn60.1 (compound Y) inhibits lung inflammation induced by LPS in mice
Source: International Congress 2014 – Animal models in respiratory drug development
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept